日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Strategic sequencing of bladder-sparing therapies in the management of BCG-unresponsive non-muscle invasive bladder cancer

针对卡介苗治疗无效的非肌层浸润性膀胱癌,制定保留膀胱治疗的策略性顺序

Abou Chakra, Mohamad; Boormans, Joost L; Hayne, Dickon; O'Donnell, Michael A

The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study

膀胱切除术后阳性手术切缘对肿瘤预后的影响:一项全国性研究

Bosveld, Jikke; Nguyen, Tri Q; Boormans, Joost L; Witjes, J Alfred; van der Heijden, Antoine G; Mehra, Niven; Kiemeney, Lambertus A; Aben, Katja K H; Meijer, Richard P; Richters, Anke

Carbon footprint and staff demands of surgery and chemoradiation for muscle-invasive bladder cancer

肌层浸润性膀胱癌手术和放化疗的碳足迹和医护人员需求

Rutten, Vera C; Hesseling, Simone A W; Franckena, Martine; Zuiverloon, Tahlita C M; Robbrecht, Debbie G J; IJzerman, Maarten J; Lin, Wenxin; Mes, Daan; Hunfeld, Nicole; Boormans, Joost L

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG

在高危非肌层浸润性膀胱癌中,PD-L1表达并非卡介苗疗效的生物标志物。

de Jong, Florus C; Kvikstad, Vebjørn; Hoedemaeker, Robert F; van der Made, Angelique C J; van der Bosch, Thierry P; van Casteren, Niels J; van Kessel, Kim E M; Zwarthoff, Ellen C; Boormans, Joost L; Zuiverloon, Tahlita C M

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy

组织学分级是肌层浸润性尿路上皮膀胱癌的有效参数吗?一项多中心研究探讨了不同分级系统对根治性膀胱切除术后无病生存期的影响。

Rinderknecht, Emily; Claps, Francesco; Bostrom, Peter J; Shariat, Shahrokh F; Neuzillet, Yann; Zlotta, Alexandre R; Trombetta, Carlo; Eckstein, Markus; Lijnen, Renee A G; Mertens, Laura S; Bussani, Rossana; Burger, Maximilian; van Leenders, Geert J L H; Boormans, Joost L; Wullich, Bernd; Hartmann, Arndt; Pavan, Nicola; Pouessel, Damien; van der Kwast, Theo H; Allory, Yves; Zuiverloon, Tahlita C M; Lotan, Yair; van Rhijn, Bas W G; Mayr, Roman

Cost-effectiveness of a randomized controlled trial comparing low-dose aspirin to placebo for the prevention of recurrent preterm birth

一项比较低剂量阿司匹林与安慰剂预防复发性早产的随机对照试验的成本效益分析

Landman, Anadeijda J E M C; Broulikova, Hana M; Visser, Laura; Nijman, Tobias A J; Hemels, Marieke A C; Vollebregt, Karin C; Boormans, Elisabeth M A; Bremer, Henk A; Tuinman, Esther; Langenveld, Josje; van der Made, Flip; Rijnders, Robbert J P; van Vliet, Huib A A M; Freeman, Liv M; de Heus, Roel; Blaauw, Judith; Krabbendam, Ineke; van de Laar, Rafli; Verberg, Marieke F G; Scheepers, Hubertina C J; Mol, Ben W; de Groot, Christianne J M; Oudijk, Martijn A; Bosmans, Judith E; de Boer, Marjon A

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer

基于基因表达的T细胞-基质富集(TSE)评分可预测尿路上皮癌对免疫检查点抑制剂的反应

Rijnders, Maud; Nakauma-González, J Alberto; Robbrecht, Debbie G J; Gil-Jimenez, Alberto; Balcioglu, Hayri E; Oostvogels, Astrid A M; Aarts, Maureen J B; Boormans, Joost L; Hamberg, Paul; van der Heijden, Michiel S; Szabados, Bernadett E; van Leenders, Geert J L H; Mehra, Niven; Voortman, Jens; Westgeest, Hans M; de Wit, Ronald; van der Veldt, Astrid A M; Debets, Reno; Lolkema, Martijn P

Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature

对转移性尿路上皮癌中APOBEC基因突变进行全基因组定位,鉴定出驱动热点突变和一种新的突变特征。

Nakauma-González, J Alberto; Rijnders, Maud; Noordsij, Minouk T W; Martens, John W M; van der Veldt, Astrid A M; Lolkema, Martijn P J; Boormans, Joost L; van de Werken, Harmen J G

Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

接受上尿路尿路上皮癌根治性手术的患者健康相关生活质量的短期变化:一项前瞻性 II 期临床试验的结果

van Doeveren, Thomas; Remmers, Sebastiaan; Atema, Vera; van den Bergh, Roderick C N; Boevé, Egbert R; Cornel, Erik B; van der Heijden, Antoine G; Hendricksen, Kees; Cauberg, Evelyne C C; Jacobs, Rens A L; Kroon, Bin K; Leliveld, Annemarie M; Meijer, Richard P; Merks, Bob; Oddens, Jorg R; Roelofs, Luc; Somford, Diederik M; de Vries, Peter; Wijsman, Bart; Windt, Willemijn A K M; Zwaan, Peter J; van Leeuwen, Pim J; Boormans, Joost L; Aben, Katja K H

A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing

一种基于深度学习的工作流程,用于从H&E染色切片中预测上尿路尿路上皮癌的蛋白质亚型,从而支持对患者进行分子检测的优先排序。

Angeloni, Miriam; van Doeveren, Thomas; Lindner, Sebastian; Volland, Patrick; Schmelmer, Jorina; Foersch, Sebastian; Matek, Christian; Stoehr, Robert; Geppert, Carol I; Heers, Hendrik; Wach, Sven; Taubert, Helge; Sikic, Danijel; Wullich, Bernd; van Leenders, Geert Jlh; Zaburdaev, Vasily; Eckstein, Markus; Hartmann, Arndt; Boormans, Joost L; Ferrazzi, Fulvia; Bahlinger, Veronika